# FDA Inspection 1007257 - MedImmune U.K. Limited - February 17, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/medimmune-uk-limited/4df68c11-603c-4978-bfbf-3da64ff085d5
Source feed: FDA_Inspections

> FDA Inspection 1007257 for MedImmune U.K. Limited on February 17, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1007257
- Company Name: MedImmune U.K. Limited
- Inspection Date: 2017-02-17
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1258494 - 2024-05-16](https://www.globalkeysolutions.net/records/fda_inspections/medimmune-uk-limited/3492ffa5-acf0-488a-af4a-e598b435f818)
- [FDA Inspection 1232941 - 2024-03-15](https://www.globalkeysolutions.net/records/fda_inspections/medimmune-uk-limited/654e6fe6-548b-47a4-a173-a171b4d7023a)
- [FDA Inspection 1175803 - 2022-06-14](https://www.globalkeysolutions.net/records/fda_inspections/medimmune-uk-limited/72823d1f-90c5-46d7-9bd4-4655520a0ebe)
- [FDA Inspection 1059831 - 2018-06-08](https://www.globalkeysolutions.net/records/fda_inspections/medimmune-uk-limited/b11fb191-da54-4f46-a09b-d2e5a19dbad4)
- [FDA Inspection 928280 - 2015-05-13](https://www.globalkeysolutions.net/records/fda_inspections/medimmune-uk-limited/3121f261-544f-45cc-8b93-b8699e3270bf)

Company: https://www.globalkeysolutions.net/companies/medimmune-uk-limited/fbddd1ed-5a0c-4c65-a48e-bb2af79482ed

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c